BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15830218)

  • 1. The residue E351 is essential for the activity of human 21-hydroxylase: evidence from a naturally occurring novel point mutation compared with artificial mutants generated by single amino acid substitutions.
    Krone N; Riepe FG; Grötzinger J; Partsch CJ; Brämswig J; Sippell WG
    J Mol Med (Berl); 2005 Jul; 83(7):561-8. PubMed ID: 15830218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional characterization of two novel point mutations in the CYP21 gene causing simple virilizing forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Krone N; Riepe FG; Grötzinger J; Partsch CJ; Sippell WG
    J Clin Endocrinol Metab; 2005 Jan; 90(1):445-54. PubMed ID: 15483094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three novel point mutations of the CYP21 gene detected in classical forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Krone N; Riepe FG; Partsch CJ; Vorhoff W; Brämswig J; Sippell WG
    Exp Clin Endocrinol Diabetes; 2006 Mar; 114(3):111-7. PubMed ID: 16636976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional and structural consequences of a novel point mutation in the CYP21A2 gene causing congenital adrenal hyperplasia: potential relevance of helix C for P450 oxidoreductase-21-hydroxylase interaction.
    Riepe FG; Hiort O; Grötzinger J; Sippell WG; Krone N; Holterhus PM
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2891-5. PubMed ID: 18445671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Four novel missense mutations in the CYP21A2 gene detected in Russian patients suffering from the classical form of congenital adrenal hyperplasia: identification, functional characterization, and structural analysis.
    Grischuk Y; Rubtsov P; Riepe FG; Grötzinger J; Beljelarskaia S; Prassolov V; Kalintchenko N; Semitcheva T; Peterkova V; Tiulpakov A; Sippell WG; Krone N
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4976-80. PubMed ID: 16984992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analyzing the functional and structural consequences of two point mutations (P94L and A368D) in the CYP11B1 gene causing congenital adrenal hyperplasia resulting from 11-hydroxylase deficiency.
    Krone N; Grischuk Y; Müller M; Volk RE; Grötzinger J; Holterhus PM; Sippell WG; Riepe FG
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2682-8. PubMed ID: 16670167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three novel CYP21A2 mutations and their protein modelling in patients with classical 21-hydroxylase deficiency from northeastern Iran.
    Baradaran-Heravi A; Vakili R; Robins T; Carlsson J; Ghaemi N; A'rabi A; Abbaszadegan MR
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):335-41. PubMed ID: 17573904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional and structural analysis of four novel mutations of CYP21A2 gene in Italian patients with 21-hydroxylase deficiency.
    Massimi A; Malaponti M; Federici L; Vinciguerra D; Manca Bitti ML; Vottero A; Ghizzoni L; Maccarrone M; Cappa M; Bernardini S; Porzio O
    Horm Metab Res; 2014 Jun; 46(7):515-20. PubMed ID: 24799024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rare CYP 21 mutation (p.E431K) induced deactivation of CYP 21A2 and resulted in congenital adrenal hyperplasia.
    Kawashima Y; Usui T; Fujimoto M; Miyahara N; Nishimura R; Hanaki K; Kanzaki S
    Endocr J; 2015; 62(1):101-6. PubMed ID: 25319875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional analysis of two recurrent amino acid substitutions in the CYP21 gene from Italian patients with congenital adrenal hyperplasia.
    Barbaro M; Lajic S; Baldazzi L; Balsamo A; Pirazzoli P; Cicognani A; Wedell A; Cacciari E
    J Clin Endocrinol Metab; 2004 May; 89(5):2402-7. PubMed ID: 15126570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital adrenal hyperplasia due to 11-hydroxylase deficiency: functional characterization of two novel point mutations and a three-base pair deletion in the CYP11B1 gene.
    Krone N; Riepe FG; Götze D; Korsch E; Rister M; Commentz J; Partsch CJ; Grötzinger J; Peter M; Sippell WG
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3724-30. PubMed ID: 15755848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis of four CYP21 mutations from spanish patients with congenital adrenal hyperplasia.
    Nunez BS; Lobato MN; White PC; Meseguer A
    Biochem Biophys Res Commun; 1999 Sep; 262(3):635-7. PubMed ID: 10471376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research Resource: Correlating Human Cytochrome P450 21A2 Crystal Structure and Phenotypes of Mutations in Congenital Adrenal Hyperplasia.
    Pallan PS; Lei L; Wang C; Waterman MR; Guengerich FP; Egli M
    Mol Endocrinol; 2015 Sep; 29(9):1375-84. PubMed ID: 26172259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel non-classic CYP21A2 variants, including combined alleles, identified in patients with congenital adrenal hyperplasia.
    Karlsson L; de Paula Michelatto D; Lusa ALG; D'Almeida Mgnani Silva C; Östberg LJ; Persson B; Guerra-Júnior G; Valente de Lemos-Marini SH; Baldazzi L; Menabó S; Balsamo A; Greggio NA; Palandi de Mello M; Barbaro M; Lajic S
    Clin Biochem; 2019 Nov; 73():50-56. PubMed ID: 31344365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substitution at residue 473 confers progesterone 21-hydroxylase activity to cytochrome P450 2C2.
    Ramarao M; Kemper B
    Mol Pharmacol; 1995 Sep; 48(3):417-24. PubMed ID: 7565621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular model of human CYP21 based on mammalian CYP2C5: structural features correlate with clinical severity of mutations causing congenital adrenal hyperplasia.
    Robins T; Carlsson J; Sunnerhagen M; Wedell A; Persson B
    Mol Endocrinol; 2006 Nov; 20(11):2946-64. PubMed ID: 16788163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p.H62L, a rare mutation of the CYP21 gene identified in two forms of 21-hydroxylase deficiency.
    Menassa R; Tardy V; Despert F; Bouvattier-Morel C; Brossier JP; Cartigny M; Morel Y
    J Clin Endocrinol Metab; 2008 May; 93(5):1901-8. PubMed ID: 18319307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
    Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional analysis of two rare CYP21A2 mutations detected in Italian patients with a mildest form of congenital adrenal hyperplasia.
    Concolino P; Vendittelli F; Mello E; Minucci A; Carrozza C; Rossodivita A; Giardina B; Zuppi C; Capoluongo E
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):470-6. PubMed ID: 19170707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP21 mutations in simple virilizing congenital adrenal hyperplasia.
    Lajić S; Robins T; Krone N; Schwarz HP; Wedell A
    J Mol Med (Berl); 2001 Oct; 79(10):581-6. PubMed ID: 11692155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.